Easton Pharmaceuticals, Inc. (EAPH)

[wjb007]

Easton is awaiting on approval from council on a revised press release stemming from a closed sub-distribution agreement recently executed with a premier, internationally brand recognized, multi-national Pharmaceuticals company for product VS-Sense (Vagi Sense). After several delays, final approval on the revised press release is expected soon. In addition, Easton expects to make some significant update announcements through its Alliance partnership which involves sales stemming from its aggregate operations and its medical marijuana business. Alliance Group believes recent federal changes in the medical marijuana industry in the United States are not expected to affect its MMJ plans and initiatives in Canada which will be demonstrated shortly.